New Age Alpha Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
New Age Alpha Advisors's BMY Position: Q2 2026 in Review
New Age Alpha Advisors increased its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, buying an estimated $220K and bringing the position to 24,805 shares worth $1.43M. The position accounts for 0.06% of the portfolio, ranked #377.
New Age Alpha Advisors first reported a position in BMY in Q4 2024 and has held it in 4 quarters since. The position peaked at $7.11M in Q4 2024. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- New Age Alpha Advisors held 24,805 shares of Bristol-Myers Squibb worth $1.43M as of Q2 2026.
- New Age Alpha Advisors bought 3,839 Bristol-Myers Squibb shares in Q2 2026, an estimated $220K.
- Bristol-Myers Squibb made up 0.06% of New Age Alpha Advisors's portfolio in Q2 2026, its #377 holding.
- New Age Alpha Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 4 quarters since.
- New Age Alpha Advisors's Bristol-Myers Squibb position peaked at $7.11M in Q4 2024.
- 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.